Vis enkel innførsel

dc.contributor.authorZwarenstein, Merricknb_NO
dc.contributor.authorTreweek, Shaunnb_NO
dc.contributor.authorGagnier, Joel Jnb_NO
dc.contributor.authorAltman, Douglas Gnb_NO
dc.contributor.authorTunis, Seannb_NO
dc.contributor.authorHaynes, Briannb_NO
dc.contributor.authorOxman, Andrew Davidnb_NO
dc.contributor.authorMoher, Davidnb_NO
dc.date.accessioned2008-11-23T15:17:11Znb_NO
dc.date.accessioned2016-02-08T14:19:41Z
dc.date.available2008-11-23T15:17:11Znb_NO
dc.date.available2016-02-08T14:19:41Z
dc.date.issued2008-11-11nb_NO
dc.identifier.citationBMJ 2008, 337:a2390en
dc.identifier.issn1468-5833nb_NO
dc.identifier.urihttp://hdl.handle.net/11250/2377873
dc.description.abstractBACKGROUND: The CONSORT statement is intended to improve reporting of randomised controlled trials and focuses on minimising the risk of bias (internal validity). The applicability of a trial's results (generalisability or external validity) is also important, particularly for pragmatic trials. A pragmatic trial (a term first used in 1967 by Schwartz and Lellouch) can be broadly defined as a randomised controlled trial whose purpose is to inform decisions about practice. This extension of the CONSORT statement is intended to improve the reporting of such trials and focuses on applicability. Methods At two, two-day meetings held in Toronto in 2005 and 2008, we reviewed the CONSORT statement and its extensions, the literature on pragmatic trials and applicability, and our experiences in conducting pragmatic trials. Recommendations We recommend extending eight CONSORT checklist items for reporting of pragmatic trials: the background, participants, interventions, outcomes, sample size, blinding, participant flow, and generalisability of the findings. These extensions are presented, along with illustrative examples of reporting, and an explanation of each extension. Adherence to these reporting criteria will make it easier for decision makers to judge how applicable the results of randomised controlled trials are to their own conditions. Empirical studies are needed to ascertain the usefulness and comprehensiveness of these CONSORT checklist item extensions. In the meantime we recommend that those who support, conduct, and report pragmatic trials should use this extension of the CONSORT statement to facilitate the use of trial results in decisions about health care.en
dc.language.isoengen
dc.publisherBMJen
dc.relation.urihttp://www.bmj.com/cgi/content/full/337/nov11_2/a2390en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806en
dc.subject.meshPublishingen
dc.subject.meshQuality Controlen
dc.subject.meshResearch Designen
dc.titleImproving the reporting of pragmatic trials: an extension of the CONSORT statement.en
dc.typeJournal articleen
dc.typePeer revieweden
dc.source.journalThe BMJen
dc.identifier.doidoi: 10.1136/bmj.a2390nb_NO
dc.identifier.pmid19001484nb_NO
dc.contributor.departmentHealth Services Sciences, Sunnybrook Hospital, Toronto, Ontario, Canada. merrick.zwarenstein@ices.on.caen


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel